Bree Mitchell serves as Senior Director of Translational Medicine and Innovation at Natera, where leadership in an early cancer detection program leverages cell-free DNA technology to enhance personalized healthcare. Previously, Bree held roles such as Director of Translational Medicine at BLOODPAC and Executive Director of the Cancer Early Detection Advanced Research Center at OHSU, focusing on innovative solutions for lethal cancer detection. Bree's extensive experience includes strategic positions at Stanford University School of Medicine, Life Technologies, and Promega Biosystems, with a foundational background in research at Fred Hutchinson Cancer Research Center. Educational credentials include a Ph.D. in Molecular Biology and an MS in Epidemiology from the University of Washington, along with a BS in Biology from the University of the Pacific.
This person is not in the org chart
This person is not in any teams
This person is not in any offices